NCT04638920View on ClinicalTrials.gov

Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
COPD Exacerbation
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

8091

University Hospital Zurich, Zurich

Sponsors
All Listed Sponsors
collaborator

Deep Breath Intelligence (DBI)

UNKNOWN

lead

Malcolm Kohler

OTHER

NCT04638920 - Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy | Biotech Hunter | Biotech Hunter